# Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/neurology/generalneurology/123918) · 2026-11-17 · Medicine
Page: https://themorning.science/story/blood-test-predicts-dementia-diabetes-and-alzheimer-s-parkinson-s-data-retracted-198c1f0eeaa105c0
Kind: research · Impact: medium

## In brief

- A Mayo Clinic study in JAMA Neurology found that blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of mild cognitive impairment and dementia.
- The study cohort consisted of cognitively unimpaired individuals.
- The authors say the blood marker may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia up to 10 years ahead.

## Why it matters

A blood test could eventually help identify people without symptoms who face higher future risk of cognitive decline, which matters for research on early detection of Alzheimer's disease.

## Timeline

- 2026-11-17: Mayo Clinic study on blood p-tau217 and dementia risk published in JAMA Neurology

## Coverage

- [Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead](https://medicalxpress.com/news/2026-11-alzheimer-blood-marker-cognitive-impairment.html) — Medical Xpress - latest medical and health news stories, 2026-11-17
- [Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted](https://www.medpagetoday.com/neurology/generalneurology/123918) — MedPageToday.com - medical news for physicians, 2026-11-17

Tags: alzheimer's, dementia, blood biomarker, p-tau217, neurology, cognitive decline

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
